HNF-4 α Antibodies

Santa Cruz Biotechnology provides a broad selection of HNF-4 α monoclonal antibodies for research focused on this critical transcription factor. HNF-4 α Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HNF-4 α (Hepatocyte Nuclear Factor 4 Alpha) plays an essential role in regulating genes involved in glucose and lipid metabolism, making it a key player in maintaining metabolic homeostasis. Dysfunction of HNF-4 α is associated with several metabolic disorders, including diabetes and obesity, highlighting its significance in both basic and clinical research. Understanding HNF-4 α function can provide insights into therapeutic targets for metabolic conditions. Research has shown that HNF-4 α influences hepatic development and maintains liver function throughout adult life. Studies indicate that HNF-4 α also impacts intestinal development and function, suggesting broader physiological roles than initially understood. Recent findings demonstrate that HNF-4 α may serve as a potential therapeutic target for various metabolic diseases. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of HNF-4 α's role in health and disease.